Date: 12 Oct 2021
Guest Speaker: Irene Chu, Head of New Economy, Head of Life Sciences, Hong Kong, KPMG China
Committee: Innovation & Technology
Our member Irene Chu shared an overview of Hong Kong’s biotech landscape. The focus was on the capital market developments, venture capital investment trends, Hong Kong government’s funding and infrastructure support for the Biomedical sector, and development opportunities in the Greater Bay Area.
